| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.17B | +29.8% |
| Cost of Revenue | $552.5M | +45.9% |
| Gross Profit | $1.62B | +25.1% |
| R&D Expense | $512.5M | +21.6% |
| SG&A Expense | $389.3M | +39.8% |
| Operating Income | -$207.2M | -33.9% |
| Pre-tax Income | -$92.7M | -30.8% |
| Income Tax | $9.6M | +20.6% |
| Net Income | -$102.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $943.5M | +538.9% |
| Accounts Receivable | $382.5M | +20.8% |
| Current Assets | $4.64B | +104.7% |
| Total Assets | $6.04B | +82.9% |
| Current Liabilities | $2.35B | +196.2% |
| Total Liabilities | $4.58B | +103.0% |
| Stockholders' Equity | $1.46B | +39.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $603.1M | +58.5% |
| Capital Expenditures | $315.6M | +70.6% |
| Investing Cash Flow | -$1.81B | -447.1% |
| Financing Cash Flow | $2.00B | — |
| Free Cash Flow | $287.5M | +47.1% |
| -29.8% |
| EPS (Basic) | -$0.29 | -26.1% |
| EPS (Diluted) | -$0.29 | -26.1% |